A rare case of orbital hodgkin lymphoma demonstrating therapeutic response to a novel systemic medication. (2nd January 2017)

• Record Type: Journal Article
• Authors: Wajda, Brynn N.; Rabinowitz, Michael P.
• Is Part Of: Orbit. Volume 36:Number 1(2017)
• Page Start: 52
• Page End: 54
• Publication Date: 2017-01-02
• Subjects: Brentuximab -- Hodgkin -- lymphoma -- orbit; Eye-sockets -- Surgery -- Periodicals; Eye-sockets -- Diseases -- Periodicals; Orbit -- surgery -- Periodicals; Orbital Diseases -- Periodicals; 617.7
• DOI: 10.1080/01676830.2016.1243133
• Languages: English
• ISSNs: 0167-6830

Abstract

ABSTRACT: Orbital Hodgkin lymphoma is infrequent, representing less than 1% of adult orbital malignancies. It is typically seen in the setting of terminally advanced systemic disease. This case highlights orbital, head, and neck disease in a systemically stable individual treated with the novel anti-CD30 monoclonal antibody brentuximab vedotin.